Paul S. Albert
National Institutes of Health · 568 works · 24,799 citations · h-index 75
Top works
- Models for Longitudinal Data: A Generalized Estimating Equation Approach
- Guidelines for the use of magnetic resonance techniques in monitoring the treatment of multiple sclerosis
- Phase II Trial of Single-Agent Bevacizumab Followed by Bevacizumab Plus Irinotecan at Tumor Progression in Recurrent Glioblastoma
- Using gadolinium‐enhanced magnetic resonance imaging lesions to monitor disease activity in multiple sclerosis
- Prevention and treatment of chronic relapsing experimental allergic encephalomyelitis by transforming growth factor-beta 1
- Role of B7:CD28/CTLA-4 in the induction of chronic relapsing experimental allergic encephalomyelitis.
- Clinical worsening in multiple sclerosis is associated with increased frequency and area of gadopentetate dimeglumine–enhancing magnetic resonance imaging lesions
- The effect of interferon‐β on blood—brain barrier disruptions demonstrated by constrast‐enhanced magnetic resonance imaging in relapsing—remitting multiple sclerosis
- Statistical Models for Longitudinal Studies of Health.
- A Cautionary Note on the Robustness of Latent Class Models for Estimating Diagnostic Error without a Gold Standard
- Longitudinal data analysis (repeated measures) in clinical trials
- Electroacupuncture for Control of Myeloablative Chemotherapy–Induced Emesis
- Racial/ethnic standards for fetal growth: the NICHD Fetal Growth Studies
- Changes in the amount of diseased white matter over time in patients with relapsing-remitting multiple sclerosis
- Limitations of the Case-only Design for Identifying Gene-Environment Interactions
- The secondarily generalized tonic‐clonic seizure
- Evidence of endogenous regulatory function of transforming growth factor-β1 in experimental allergic encephalomyelitis
- Dynamic Contrast-Enhanced MRI of Prostate Cancer at 3 T: A Study of Pharmacokinetic Parameters
- Serum Hormones and the Alcohol-Breast Cancer Association in Postmenopausal Women
- Use of complementary/alternative therapies by women with advanced-stage breast cancer